Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 7/20 | 0.61 |
| ▸ | KDM5A | P29375 | 1/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | SCN4A | P35499 | 2/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.37 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | REV1 | Q9UBZ9 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6829078 | 0.94 | NPY5R (0.63) | NPY5RROCK2ROCK1MAPK8MAPK10 | |
| SCHEMBL6824384 | 0.91 | NPY5R (0.59) | NPY5RKDM5ASCN4AMAPTLMNA | |
| SCHEMBL6823457 | 0.88 | NPY5R (0.62) | NPY5RMAPTLMNATP53KMT2A | |
| SCHEMBL6823480 | 0.88 | NPY5R (0.56) | NPY5RMAPK8KMT2AEPHX2 | |
| SCHEMBL6823387 | 0.87 | NPY5R (0.61) | NPY5RMAPTLMNATP53KMT2A | |
| SCHEMBL6826590 | 0.86 | NPY5R (0.60) | NPY5RMAPTKMT2APOLB | |
| SCHEMBL6829275 | 0.85 | NPY5R (0.69) | NPY5RKDM5AMAPTREV1TP53 | |
| SCHEMBL6826986 | 0.84 | NPY5R (0.67) | NPY5RMAPTREV1 | |
| SCHEMBL6829077 | 0.84 | NPY5R (0.61) | NPY5RMAPTLMNATP53POLB | |
| SCHEMBL6829075 | 0.83 | NPY5R (0.66) | NPY5RMAPTREV1TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040067999-A1 | Carbazole derivatives and their use as neuropeptide y5 receptor ligands | ASTRAZENECA AB (SE) | 2004-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040067999-A1 | Carbazole derivatives and their use as neuropeptide y5 receptor ligands | NPY5R, NPY1R, NPY2R | NPY5R 1/4885KDM5A 794/4885ROCK2 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.